228 related articles for article (PubMed ID: 19619138)
1. Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model.
Choi JH; Berger JD; Mazzella MJ; Morales-Corraliza J; Cataldo AM; Nixon RA; Ginsberg SD; Levy E; Mathews PM
J Neurochem; 2009 Sep; 110(6):1818-27. PubMed ID: 19619138
[TBL] [Abstract][Full Text] [Related]
2. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
3. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
Chen XQ; Salehi A; Pearn ML; Overk C; Nguyen PD; Kleschevnikov AM; Maccecchini M; Mobley WC
Alzheimers Dement; 2021 Feb; 17(2):271-292. PubMed ID: 32975365
[TBL] [Abstract][Full Text] [Related]
4. Temporal and brain region-specific elevations of soluble Amyloid-β
Tallino S; Winslow W; Bartholomew SK; Velazquez R
Aging Cell; 2022 Apr; 21(4):e13590. PubMed ID: 35290711
[TBL] [Abstract][Full Text] [Related]
5. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
[TBL] [Abstract][Full Text] [Related]
6. Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.
Peng S; Garzon DJ; Marchese M; Klein W; Ginsberg SD; Francis BM; Mount HT; Mufson EJ; Salehi A; Fahnestock M
J Neurosci; 2009 Jul; 29(29):9321-9. PubMed ID: 19625522
[TBL] [Abstract][Full Text] [Related]
7. Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice.
Seo H; Isacson O
Exp Neurol; 2005 Jun; 193(2):469-80. PubMed ID: 15869949
[TBL] [Abstract][Full Text] [Related]
8. GABAergic hyperinnervation of dentate granule cells in the Ts65Dn mouse model of down syndrome: Exploring the role of App.
Mojabi FS; Fahimi A; Moghadam S; Moghadam S; Windy McNerneny M; Ponnusamy R; Kleschevnikov A; Mobley WC; Salehi A
Hippocampus; 2016 Dec; 26(12):1641-1654. PubMed ID: 27701794
[TBL] [Abstract][Full Text] [Related]
9. Restoring microglial and astroglial homeostasis using DNA immunization in a Down Syndrome mouse model.
Illouz T; Madar R; Biragyn A; Okun E
Brain Behav Immun; 2019 Jan; 75():163-180. PubMed ID: 30389461
[TBL] [Abstract][Full Text] [Related]
10. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA
J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772
[TBL] [Abstract][Full Text] [Related]
11. The App-Runx1 region is critical for birth defects and electrocardiographic dysfunctions observed in a Down syndrome mouse model.
Raveau M; Lignon JM; Nalesso V; Duchon A; Groner Y; Sharp AJ; Dembele D; Brault V; Hérault Y
PLoS Genet; 2012 May; 8(5):e1002724. PubMed ID: 22693452
[TBL] [Abstract][Full Text] [Related]
12. Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner.
Blazek JD; Malik AM; Tischbein M; Arbones ML; Moore CS; Roper RJ
Mech Dev; 2015 May; 136():133-42. PubMed ID: 25556111
[TBL] [Abstract][Full Text] [Related]
13. Evidence against the overexpression of APP in Down syndrome.
Argellati F; Massone S; d'Abramo C; Marinari UM; Pronzato MA; Domenicotti C; Ricciarelli R
IUBMB Life; 2006 Feb; 58(2):103-6. PubMed ID: 16608822
[TBL] [Abstract][Full Text] [Related]
14. Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome.
Hunter CL; Isacson O; Nelson M; Bimonte-Nelson H; Seo H; Lin L; Ford K; Kindy MS; Granholm AC
Neurosci Res; 2003 Apr; 45(4):437-45. PubMed ID: 12657457
[TBL] [Abstract][Full Text] [Related]
15. Whether Alzheimer's diseases related genes also differently express in the hippocampus of Ts65Dn mice?
Zhang B; Wang Q; Miao T; Yu B; Yuan P; Kong J; Lu B
Int J Clin Exp Pathol; 2015; 8(4):4120-5. PubMed ID: 26097601
[TBL] [Abstract][Full Text] [Related]
16. Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP.
Sano Y; Nakaya T; Pedrini S; Takeda S; Iijima-Ando K; Iijima K; Mathews PM; Itohara S; Gandy S; Suzuki T
PLoS One; 2006 Dec; 1(1):e51. PubMed ID: 17183681
[TBL] [Abstract][Full Text] [Related]
17. Skeletal Deficits in Male and Female down Syndrome Model Mice Arise Independent of Normalized Dyrk1a Expression in Osteoblasts.
Thomas JR; Sloan K; Cave K; Wallace JM; Roper RJ
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828335
[TBL] [Abstract][Full Text] [Related]
18. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.
Boix CP; Lopez-Font I; Cuchillo-Ibañez I; Sáez-Valero J
Alzheimers Res Ther; 2020 Aug; 12(1):96. PubMed ID: 32787955
[TBL] [Abstract][Full Text] [Related]
19. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
Asai M; Kawakubo T; Mori R; Iwata N
Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
[TBL] [Abstract][Full Text] [Related]
20. A pleiotropic role for exosomes loaded with the amyloid β precursor protein carboxyl-terminal fragments in the brain of Down syndrome patients.
Pérez-González R; Gauthier SA; Sharma A; Miller C; Pawlik M; Kaur G; Kim Y; Levy E
Neurobiol Aging; 2019 Dec; 84():26-32. PubMed ID: 31479861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
